Cargando…

Healthcare utilization and management of actinic keratosis in primary and secondary care: a complementary database analysis

BACKGROUND: The high prevalence of actinic keratosis (AK) requires the optimal use of healthcare resources. OBJECTIVES: To gain insight in to the healthcare utilization of people with AK in a population‐based cohort, and the management of AK in a primary and secondary care setting. METHODS: A retros...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noels, E. C., Hollestein, L. M., van Egmond, S., Lugtenberg, M., van Nistelrooij, L. P. J., Bindels, P. J. E., van der Lei, J., Stern, R. S., Nijsten, T., Wakkee, M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6850060/ https://www.ncbi.nlm.nih.gov/pubmed/30636037 http://dx.doi.org/10.1111/bjd.17632

Ejemplares similares

Insight into the management of actinic keratosis: a qualitative interview study among general practitioners and dermatologists
por: Noels, E.C., et al.
Publicado: (2019)

What are the most important factors in basal cell carcinoma follow‐up care? The perspective of patients
por: van Egmond, S., et al.
Publicado: (2020)

Substitution of low-risk skin cancer hospital care towards primary care: A qualitative study on views of general practitioners and dermatologists
por: Noels, E. C., et al.
Publicado: (2019)

Process evaluation of a multicentre randomised clinical trial of substituting surgical excisions of low-risk basal cell carcinomas from secondary to primary care
por: Noels, Eline, et al.
Publicado: (2022)

Predicting keratinocyte carcinoma in patients with actinic keratosis: development and internal validation of a multivariable risk‐prediction model
por: Tokez, S., et al.
Publicado: (2020)

Factors influencing current low‐value follow‐up care after basal cell carcinoma and suggested strategies for de‐adoption: a qualitative study
por: van Egmond, S., et al.
Publicado: (2019)

Views on mobile health apps for skin cancer screening in the general population: an in‐depth qualitative exploration of perceived barriers and facilitators
por: Sangers, T.E., et al.
Publicado: (2021)

Limited impact of COVID‐19‐related diagnostic delay on cutaneous melanoma and squamous cell carcinoma tumour characteristics: a nationwide pathology registry analysis
por: Sangers, Tobias E., et al.
Publicado: (2022)

The Genomic Landscape of Actinic Keratosis
por: Thomson, Jason, et al.
Publicado: (2021)

Towards successful implementation of artificial intelligence in skin cancer care: a qualitative study exploring the views of dermatologists and general practitioners
por: Sangers, Tobias E., et al.
Publicado: (2022)

Complex skin cancer treatment requiring reconstructive plastic surgery: an interview study on the experiences and needs of patients
por: van Egmond, Sven, et al.
Publicado: (2021)

A feasibility study of microwave therapy for precancerous actinic keratosis
por: Jackson, D.N., et al.
Publicado: (2020)

Actinic Keratosis: Rationale and Management
por: Dodds, Annabel, et al.
Publicado: (2014)

Optimal treatment of actinic keratosis
por: Goldenberg, Gary
Publicado: (2013)

Virtual consultation for actinic keratosis
por: Dhariwal, Sukhjit, et al.
Publicado: (2020)

Patient‐reported skin reactions to 5% 5‐fluorouracil in treatment of actinic keratosis
por: Ahmady, S., et al.
Publicado: (2021)

Pigmented Actinic Keratosis: Case Report and Review of an Uncommon Actinic Keratosis Variant that can Mimic Melanoma
por: Abudu, Boya, et al.
Publicado: (2019)

Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis
por: Thomas, Gareth J., et al.
Publicado: (2017)

Non-adherence to topical treatments for actinic keratosis
por: Shergill, Bav, et al.
Publicado: (2013)

Retinoids for prevention and treatment of actinic keratosis*
por: Ianhez, Mayra, et al.
Publicado: (2013)

Cyclooxygenase-2 expression in actinic keratosis
por: Adamska, Kinga, et al.
Publicado: (2018)

What do patients and dermatologists prefer regarding low-risk basal cell carcinoma follow-up care? A discrete choice experiment
por: van Egmond, Sven, et al.
Publicado: (2021)

Current and emerging treatment strategies for the treatment of actinic keratosis
por: Berlin, Joshua M
Publicado: (2010)

Primary Melanoma Characteristics of Metastatic Disease: A Nationwide Cancer Registry Study
por: Zhou, Catherine, et al.
Publicado: (2021)

P21 Immunoexpression in Actinic Keratosis and Cutaneous Carcinomas
por: MARINESCU, A., et al.
Publicado: (2017)

An artificial intelligence based app for skin cancer detection evaluated in a population based setting
por: Smak Gregoor, Anna M., et al.
Publicado: (2023)

Cost for the treatment of actinic keratosis on the rise in Australia
por: Perera, Eshini, et al.
Publicado: (2014)

Efficacy Endpoints in Clinical Trials in Actinic Keratosis
por: Skov, Torsten, et al.
Publicado: (2018)

Successful Treatment of Actinic Keratosis with Kanuka Honey
por: Mane, Saras, et al.
Publicado: (2018)

Circumscribed Palmar Hypokeratosis With Superimposed Actinic Keratosis
por: Aukerman, Erica, et al.
Publicado: (2023)

Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action
por: Schlesinger, Todd, et al.
Publicado: (2022)

Unusually Aggressive Actinic Keratosis of the Eyelid and Conjunctiva
por: AL-HAGE, Jana, et al.
Publicado: (2023)

Increasing Costs of Skin Cancer due to Increasing Incidence and Introduction of Pharmaceuticals, 2007–2017
por: NOELS, Eline, et al.
Publicado: (2020)

Expert Recommendations on Facilitating Personalized Approaches to Long-term Management of Actinic Keratosis: The Personalizing Actinic Keratosis Treatment (PAKT) Project
por: MORTON, Colin, et al.
Publicado: (2023)

Validation of four cutaneous squamous cell carcinoma staging systems using nationwide data
por: Venables, Zoe Claire, et al.
Publicado: (2022)

Needs and preferences of patients regarding atopic dermatitis care in the era of new therapeutic options: a qualitative study
por: de Wijs, Linde E. M., et al.
Publicado: (2022)

Developing a risk prediction model for keratinocyte carcinoma in patients with actinic keratosis
por: Kim, Y., et al.
Publicado: (2020)

Cost–Utility of First-Line Actinic Keratosis Treatments in Finland
por: Soini, Erkki J., et al.
Publicado: (2015)

Childhood actinic keratosis in an albino transforming into squamous cell carcinoma
por: Agale, Shubhangi V., et al.
Publicado: (2012)

CD44 Immunoexpression in the Progression of Actinic Keratosis and Cutaneous Squamouscarcinoma
por: MARINESCU, A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fi0umb0spjjus0n1erd59kdq2d